Free Trial

UiPath (NYSE:PATH) Sees Large Volume Increase - Should You Buy?

UiPath logo with Computer and Technology background

Key Points

  • UiPath experienced a significant increase in trading volume, with 20.56 million shares traded, a 52% rise from the previous session, although the stock price fell from $18.51 to $18.02.
  • Wall Street analysts have mixed opinions on UiPath, with target prices ranging from $12.00 to $16.00 and an average rating of "Hold"; however, Wall Street Zen recently upgraded it to a "strong-buy."
  • Insiders have been selling shares, including CEO Daniel Dines, who sold 122,734 shares, representing a 16.67% decrease in their ownership, while institutional investors hold about 62.50% of the stock.
  • Five stocks to consider instead of UiPath.

UiPath, Inc. (NYSE:PATH - Get Free Report) saw an uptick in trading volume on Friday . 20,559,162 shares traded hands during trading, an increase of 52% from the previous session's volume of 13,486,975 shares.The stock last traded at $18.02 and had previously closed at $18.51.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on PATH. BMO Capital Markets increased their target price on UiPath from $12.50 to $13.00 and gave the company a "market perform" rating in a report on Thursday, October 2nd. DA Davidson assumed coverage on UiPath in a report on Friday, September 5th. They set a "neutral" rating and a $12.00 target price for the company. Canaccord Genuity Group lowered their price target on UiPath from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Monday, September 8th. Wall Street Zen raised UiPath from a "buy" rating to a "strong-buy" rating in a research report on Saturday, September 6th. Finally, Cowen reaffirmed a "hold" rating on shares of UiPath in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $13.21.

View Our Latest Analysis on PATH

UiPath Price Performance

The stock's fifty day moving average price is $11.87 and its 200-day moving average price is $11.98. The firm has a market cap of $9.20 billion, a price-to-earnings ratio of 579.53, a price-to-earnings-growth ratio of 5.76 and a beta of 1.07.

UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.07. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The business had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. During the same quarter in the previous year, the business earned $0.04 earnings per share. The firm's revenue was up 14.6% compared to the same quarter last year. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, equities research analysts predict that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Insider Activity at UiPath

In other UiPath news, insider Brad Brubaker sold 66,665 shares of the company's stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $15.00, for a total value of $999,975.00. Following the transaction, the insider owned 690,519 shares in the company, valued at approximately $10,357,785. This represents a 8.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Daniel Dines sold 122,734 shares of the business's stock in a transaction that occurred on Wednesday, October 8th. The stock was sold at an average price of $14.89, for a total transaction of $1,827,509.26. Following the completion of the sale, the chief executive officer directly owned 613,670 shares of the company's stock, valued at $9,137,546.30. This represents a 16.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,647,334 shares of company stock worth $21,047,369. Company insiders own 23.19% of the company's stock.

Institutional Trading of UiPath

Several large investors have recently modified their holdings of the company. Twin Peaks Wealth Advisors LLC bought a new stake in UiPath in the 2nd quarter valued at $28,000. AdvisorNet Financial Inc increased its position in shares of UiPath by 320.4% during the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock worth $32,000 after purchasing an additional 1,887 shares in the last quarter. CX Institutional bought a new position in shares of UiPath in the first quarter worth about $36,000. GAMMA Investing LLC raised its stake in shares of UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock worth $38,000 after acquiring an additional 969 shares during the last quarter. Finally, IFP Advisors Inc grew its position in shares of UiPath by 508.0% during the 2nd quarter. IFP Advisors Inc now owns 3,283 shares of the company's stock worth $42,000 after buying an additional 2,743 shares during the period. 62.50% of the stock is owned by institutional investors.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Exceptional Growth Stocks to Hold for the Long Haul
5 Stocks Congress Is Buying for the AI Boom
3 Growth Stocks Under $20 with Serious Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines